Gang Zheng

Researcher

Related Research

Multiple Cancers

Porphysome nanoparticle enabled image-guided cancer interventions - III

It’s been over a decade since the groundbreaking lipid nanoparticles (Porphysomes) were first discovered in the lab of Dr. Gang Zheng’s team at the Princess Margaret Cancer Centre (PM), Un...
Read More
Pediatric & Young Adult Cancers

Early detection and prevention of cancer in Li-Fraumeni Syndrome

A team of Toronto- and Halifax-based scientists has received renewed funding from the Terry Fox Research Institute to continue its groundbreaking research into Li-Fraumeni Syndrome (LFS)—a rare ...
Read More
Completed

Liver Cancer

Optimizing Therapy for Hepatocellular Carcinoma via Image-guided Porphysome delivery

An early-career clinician-scientist in Toronto is hoping to turn the tide on a deadly form of liver cancer with new funding from the Terry Fox Research Institute. Liver transplant specialist and clini...
Read More
Completed

Multiple Cancers

Porphysome nanoparticle-enabled image-guided cancer interventions

Renewal funding from the Terry Fox Research Institute will enable a Toronto-based research group to change the cancer imaging landscape by preventing overtreatment and, consequently, decreasing the ne...
Read More
Completed

Multiple Cancers

Nanoparticle enhanced photoacoustic imaging for cancer localization and therapeutic guidance

When you hear the words “light” and “sound” the image of a dazzling play on Broadway may come to mind. You might not think of combining them with tiny organic particles (nanopa...
Read More

Related News & Events

Research Highlight|April 28, 2025

A Canadian Cancer Discovery

Researchers funded by the Terry Fox Research Institute have developed Porphysomes – light-activated nanoparticles designed to enhance cancer surgery a...

TFRI News|September 10, 2024

TFRI reaches record high of 20 active PPGs with nearly $20 million awarded to four teams in 2024 competition for prestigious Terry Fox New Frontiers Program Project Grants

Four Canadian research teams will receive a total of $19.8 million in new and renewal funding to advance cancer research and improve treatments as the...

Research Highlight|May 09, 2023

Novel strategy to penetrate cancer cell wall yields 25-fold increase in porphyrin uptake, improving photodynamic therapy and potential drug delivery

TFRI-funded researchers have developed a novel strategy to penetrate the cancer cell wall yielding a 25-fold increase in porphyrin uptake, improving p...

Research Highlight|June 03, 2022

New clinical trial in dogs seeks to test innovative “seek and destroy” treatment that could bring new hope to pets and people with cancer

A nanoparticle developed by TFRI-funded researchers is being used for the first time as part of an innovative clinical trial in dogs that could pave t...

Research Highlight|May 06, 2022

Re-defining Li-Fraumeni Syndrome: A catchup with Dr. David Malkin, leader of the Terry Fox New Frontiers Program Project Team studying Li-Fraumeni Syndrome

Over the last four years, the team has made significant findings that better help understand, diagnose, and potentially treat this cancer predispositi...

Research Highlight|August 05, 2020